Recently, Laidlaw & Company found themselves in some tricky waters, as Relmada Therapeutics amended their compliant against Matthew Eitner and James Ahern. This is, of course, part of a lawsuit that was previously filed in Nevada District Court. What has been added to the claim is another legal claim saying that Laidlaw & Company disclosed confidential information. They are also looking to obtain monetary damages from fees and costs that it incurred in responding to Laidlaw’s false and misleading proxy items in December 2015. It will be interesting to see what, if anything, occurs from this. This is the stage they are at now, and we will have to let the courts settle it and see if it has any merit or not.
They have started up a great company that is doing wonderful things and growing, each and every day. They also bring to the table a legacy that is over 170 years. Experience counts for a lot in the investment banking industry. After all, you wouldn’t trust your money to just anyone, that is for sure. Laidlaw is a company you can trust, however, despite what is going on right now.
When you are successful, you are going to run into thing like this all of the time, as it is the nature of the beast. However, when you have a stellar reputation, great employees, and you work hard each and every day, you overcome these obstacles and you are better off in the long run because of them. This is only a road block to bigger and better things for them as a whole.